Home » Topics » Regulatory

Regulatory
RSS

Oxeze Turbuhaler approved in Canada for control and relief of asthma symptoms

March 30, 2001

Schering AG's liver-specific contrast agent approved in Sweden

March 30, 2001

Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Cyamemazine reported to successfully substitute for benzodiazepines

March 27, 2001

Pharmaceutical compositions for obstructive airways disorders claimed by AstraZeneca

March 27, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...